Improvements in recanalization with modern stroke therapy: A review of prospective ischemic stroke trials during the last two decades

Journal of NeuroInterventional Surgery

Volumn 5, Issue 6, 2013, Pages 506-511

  Fargen, Kyle M ^a   Meyers, Philip M ^b   Khatri, Pooja ^c   Mocco, J ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; MECHANICAL THROMBECTOMY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; REPERFUSION; REVIEW; SYMPTOM; TOTAL QUALITY MANAGEMENT; TREND STUDY;

INTERVENTION; STROKE; THROMBECTOMY; THROMBOLYSIS;

BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL TRIALS AS TOPIC; ENDOVASCULAR PROCEDURES; HUMANS; LINEAR MODELS; PROSPECTIVE STUDIES; REPERFUSION; STROKE; THROMBECTOMY; TREATMENT OUTCOME;

EID: 84885356286     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2012-010541     Document Type: Review

References (28)

1. Adeoye O, Hornung R, Khatri P, et al. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 2011;42:1952-5.
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
3. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703.
4. Khatri P, Hill MD, Palesch YY, et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008;3:130-7. (Pubitemid 351566847)
5. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-6.
6. Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration-Approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-Assisted recanalization in acute ischemic stroke). Stroke 2009;40:3552-6.
7. Levy EI, Rahman M, Khalessi AA, et al. Midterm clinical and angiographic follow-up for the first Food and Drug Administration-Approved prospective, single-Arm trial of primary stenting for dtroke: SARIS (Stent-Assisted Recanalization for Acute Ischemic Stroke). Neurosurgery 2011;69:915-20; discussion 920.
8. Rei D, Yoo AJ, Heck D, et al. The Penumbra START trial: preliminary results on the clinical impact of pre-treatment CTA source image ASPECTS in endovascularly-treated stroke patients. Paper presented at: International Stroke Conference; February 1, 2012, New Orleans, LA.
9. Wahlgren N. TREVO: Thrombectomy REvascularization of large Vessel Occlusions in acute ischemic stroke. International Stroke Conference; New Orleans, LA.
10. IMS Study Investigators. Combined intravenous and intra-Arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-11.
11. Furlan A, Higashida R, Wechsler L, et al. Intra-Arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11.
12. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38: 2127-35.
13. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12. (Pubitemid 351440692)
14. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8. (Pubitemid 40967507)
15. Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.
16. Costalat V, Machi P, Lobotesis K, et al. Rescue, combined, and stand-Alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device: a prospective 50-patient single-center study: timing, safety, and efficacy. Stroke 2011;42:1929-35.
17. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; this paper was E-published online, ahead of print, as of 8/24/2012.
18. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; this paper was E-published online ahead of print as of 8/24/2012 in the Lancet.
19. Saver JL. Primary results of the SOLITAIRE; With the intention for thrombectomy (SWIFT) multicenter, randomized clinical trial. Paper presented at: International Stroke Conference; February 3, 2012, New Orleans.
20. Nogueira RG, Lutsep HL, Gupta R, et al. Results from the TREVO 2 Study (Thrombectomy REvascularization of large Vessel Occlusions in acute ischemic stroke): Randomized data comparing Trevo with Merci for thrombectomy in acute stroke. European Stroke Conference; Lisbon, Portugal.
21. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
22. Riedel CH, Zimmermann P, Jensen-Kondering U, et al. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011;42:1775-7.
23. Puig J, Pedraza S, Demchuk A, et al. Quantification of thrombus Hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2012;33:90-6.
24. Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72.
25. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802-9.
26. Broderick JP. The challenges of intracranial revascularization for stroke prevention. N Engl J Med 2011;365:1054-5.
27. Broderick JP, Meyers PM. Acute stroke therapy at the crossroads. JAMA 2011;306:2026-8.
28. Khatri P, Neff J, Broderick JP, et al. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400-3. (Pubitemid 41566966)